cue-101
cue biopharma
['cue bio', 'cuebio']
today we shared new positive data from the ongoing phase 1 combination trial evaluating our lead il-2-based drug candidate for the treatment of #headandneck cancer, to be presented at s 37th annual meeting (#sitc2022). for details: 